UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 319

Sortiert nach

Behavioural and structural interventions in cancer prevention: towards the 2030 SDG horizon

Molecular oncology, 2021-03, Vol.15 (3), p.801-808

2021

Link zum Volltext

Verfügbarkeit prüfen

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

BMC cancer, 2012-06, Vol.12 (1), p.260-260

2012

Link zum Volltext

Verfügbarkeit prüfen

New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (3), p.282-294

Diaz‐Rubio, Eduardo

2004

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

The American journal of pathology, 2011-04, Vol.178 (4), p.1453-1460

2011

Link zum Volltext

Verfügbarkeit prüfen

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2171-2177

2007

Link zum Volltext

Verfügbarkeit prüfen

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition

PloS one, 2018-09, Vol.13 (9), p.e0203885-e0203885

2018

Link zum Volltext

Verfügbarkeit prüfen

Venous International Assessment, VIA scale, validated classification procedure for the peripheral venous system

The journal of vascular access, 2014-01, Vol.15 (1), p.45-50

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5910-5917

2008

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

British journal of cancer, 2018-12, Vol.119 (12), p.1464-1470

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis

Cancer treatment reviews, 2021-09, Vol.99, p.102226-102226, Article 102226

2021

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin: results in colorectal carcinoma

Critical reviews in oncology/hematology, 2002-10, Vol.44 (1), p.29-44

2002

Link zum Volltext

Verfügbarkeit prüfen

Study of KRAS new predictive marker in a clinical laboratory

Clinical & translational oncology, 2012-12, Vol.14 (12), p.937-942

2012

Link zum Volltext

Verfügbarkeit prüfen

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database

Journal of clinical oncology, 2015-01, Vol.33 (1), p.22-28

2015

Link zum Volltext

Verfügbarkeit prüfen

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

Nature communications, 2018-02, Vol.9 (1), p.575-18, Article 575

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5225-5232

2007

Link zum Volltext

Verfügbarkeit prüfen

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2084-2091

2004

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice guidelines on antiemetics in oncology

Expert review of anticancer therapy, 2005-12, Vol.5 (6), p.963-972

2005

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages

Anticancer research, 2009-11, Vol.29 (11), p.4839-4843

2009

Link zum Volltext

Verfügbarkeit prüfen

Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma : Prognostic indications

Cancer, 2006-02, Vol.106 (3), p.541-551

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(187)
Science & Technology
(181)
Life Sciences & Biomedicine
(170)
Oncology
(150)
Female
(131)
Middle Aged
(104)
Male
(89)
Aged
(87)
Adult
(78)
Biological And Medical Sciences
(54)
Medical Sciences
(53)
Tumors
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(48)
Colorectal Neoplasms - Drug Therapy
(47)
Mutation
(39)
Colorectal Cancer
(38)
Chemotherapy
(37)
Colorectal Neoplasms - Pathology
(35)
Prognosis
(35)
Aged, 80 And Over
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Behavioural and structural interventions in cancer prevention: towards the 2030 SDG horizon

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition

Venous International Assessment, VIA scale, validated classification procedure for the peripheral venous system

Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis

Oxaliplatin: results in colorectal carcinoma

Study of KRAS new predictive marker in a clinical laboratory

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Clinical practice guidelines on antiemetics in oncology

Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages

Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma : Prognostic indications

Suchergebnisse filtern